Genetic aberrations detected by comparative genomic hybridization in ovarian clear cell adenocarcinomas

Oncology

Volumn 59, Issue 1, 2000, Pages 50-56

  Suehiro, Yutaka ^a,d   Sakamoto, Masaru ^a   Umayahara, Kenji ^a,d   Iwabuchi, Hiroshi ^a   Sakamoto, Hiroko ^b   Tanaka, Naotake ^c   Takeshima, Nobuhiro ^c   Yamauchi, Kazuhiro ^c   Hasumi, Katsuhiko ^c   Akiya, Tsukasa ^a   Sakunaga, Hotaka ^a   Muroya, Tetsuya ^a   Numa, Fumitaka ^d   Kato, Hiroshi ^d   Tenjin, Yoshio ^a   Sugishita, Tadashi ^a  

^a SASAKI INSTITUTE   (Japan)

^b OLYMPUS CORPORATION   (Japan)

^c CANCER INSTITUTE HOSPITAL   (Japan)

^d YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Clear cell adenocarcinoma; Comparative genomic hybridization; Copy number abnormalities; Ovarian cancer

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 17Q; CHROMOSOME 20Q; CHROMOSOME 21Q; CHROMOSOME 8Q; CLEAR CELL CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; DNA SEQUENCE; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; OVARY ADENOCARCINOMA; PRIORITY JOURNAL;

EID: 0033919389     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012137     Document Type: Article

References (24)

1. Behbakht K, Randall TC, Benjamin I, Morgan MA, King S, Rubin SC: Clinical characteristics of clear cell carcinoma of the ovary. Gynecol Oncol 1998;70:255-258.
2. Pejovic T: Genetic changes in ovarian cancer. Ann Med 1995;27:73-78.
3. Berchuck A, Kamel A, Whitaker R, Kerns B, Olt G, Kinney R, Soper JT, Dodge R, Clarke-Pearson DL, Marks P: Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 1990;50:4087-4091.
4. Borrensen AL: Oncogenesis in ovarian cancer. Acta Obstet Gynecol Scand 1992;155:25-30.
5. Schwab M, Amler LC: Amplification of cellular oncogenes: A predictor of clinical outcome in human cancer. Genes Chromosome Cancer 1990;1:181-193.
6. Yang-Feng TL, Han H, Chen KC, Li SB, Claus EB, Carcangiu ML, Chambers SK, Chambers JT, Schwartz PE: Allelic loss in ovarian cancer. Int J Cancer 1993;54:546-551.
7. Yang-Feng TL, Li S, Han H, Schwartz PE: Frequent loss of heterozygosity on chromosomes Xp and 13q in human ovarian cancer. Int J Cancer 1992;52:575-580.
8. Isola J, DeVries S, Chu L, Ghazvini S, Waldman F: Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 1994;145:1301-1308.
9. Piper J, Rutovitz D, Sudar D, Kallioniemi A, Kallioniemi O-P, Waldman F, Gray JW, Pinkel D: Computer image analysis of comparative genomic hybridization. Cytometry 1995; 19:19-26.
10. Iwabuchi H, Sakamoto M, Sakunaga H, Ma Y-Y, Carcangiu ML, Pinkel D, Yang-Feng TL, Gray JW: Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res 1995;55:6172-6180.
11. Fuhrman SA, Lasky LC, Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6: 655-663.
12. Field JK, Kiaris H, Risk JM, Tsiriyotis C, Adamson R, Zoumpourlis V, Rowley H, Taylor K, Whittaker J, Howard P, Beirne JC, Gosney JR, Woolgar J, Vaughan ED, Spandidos DA, Jones AS: Allelotype of squamous cell carcinoma of the head and neck: Fractional allele loss correlates with survival. Br J Cancer 1995; 72:1180-1188.
13. Speicher MR, Howe C, Crotty P, du Manoir S, Costa J, Ward DC: Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res 1995;55:1010-1013.
14. Amfo K, Neyns B, Teugels E, Lissens W, Bourgain C, De Sutter P, Vandamme B, Vamos E, De Grève J: Frequent deletion of chromosome 19 and a rare rearrangement of 19p13.3 involving the insulin receptor gene in human ovarian cancer. Oncogene 1995;11:351-358.
15. Gordon KB, Thompson CT, Char DH, O'Brien JM, Kroll S, Ghazvini S, Gray JW: Comparative genomic hybridization in the detection of DNA copy number abnormalities in uveal melanoma. Cancer Res 1994;54:4764-4768.
16. Berns EM, Klijn JG, van Putten WL, van Staveren IL, Portengen H, Foekens JA: c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. Cancer Res 1992;52:1107-1113.
17. Varley JM, Swallow JE, Brammar WJ, Whittaker JL, Walker RA: Alternations to either c-erbB-2 (neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis. Oncogene 1987;1:423-430.
18. Baker VV, Borst MP, Dixon D, Hatch KD, Shingleton HM, Miller D: c-myc amplification in ovarian cancer. Gynecol Oncol 1990;38: 340-342.
19. Wang ZR, Liu W, Smith ST, Parrish RS, Young SR: c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH. Exp Mol Pathol 1999;66:140-148.
20. Diebold J, Suchy B, Baretton GB, Blasenbreu S, Meier W, Schmidt M, Rabes H, Lohrs U: DNA ploidy and MYC DNA amplification in ovarian carcinomas. Correlation with p53 and bcl-2 expression, proliferative activity and prognosis. Virchows Arch 1996;429:221-227.
21. Tanner MM, Trikkonen M, Kallioniemi A, Collins C, Stokke T, Karhu R, Kowbel D, Shadravan F, Hintz M, Kuo W-L, Waldman FM, Isola JJ, Gray JW, Kallioniemi O-P: Increased copy number at 20q13 in breast cancer: Defining the critical region and exclusion of candidate genes. Cancer Res 1994;54:4257-4260.
22. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH: Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 1996;56: 3091-3102.
23. Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A, Dejean A: Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 1997;18:59-65.
24. Nishizaki T, Ozaki S, Harada K, Ito H, Arai H, Beppu T, Sasaki K: Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization. Genes Chromosomes Cancer 1998;21: 340-346.